Next Article in Journal
Cyclodextrin-Based Nanostructure Efficiently Delivers siRNA to Glioblastoma Cells Preferentially via Macropinocytosis
Next Article in Special Issue
Superior Properties of N-Acetylcysteine Ethyl Ester over N-Acetyl Cysteine to Prevent Retinal Pigment Epithelial Cells Oxidative Damage
Previous Article in Journal
Downregulation of miR-506-3p Facilitates EGFR-TKI Resistance through Induction of Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines
Previous Article in Special Issue
Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models
Article

Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor

1
Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95125 Catania, Italy
2
Department of Drug Sciences, University of Catania, 95125 Catania, Italy
3
Oasi Research Institute—IRCCS, 94018 Troina, Italy
4
Center for Research in Ocular Pharmacology-CERFO, University of Catania, 95125 Catania, Italy
*
Author to whom correspondence should be addressed.
Consider that the first three should be regarded as joint First Authors.
Int. J. Mol. Sci. 2020, 21(23), 9305; https://doi.org/10.3390/ijms21239305
Received: 22 October 2020 / Revised: 23 November 2020 / Accepted: 4 December 2020 / Published: 6 December 2020
(This article belongs to the Special Issue Towards an Understanding of Retinal Diseases and Novel Treatment)
Activation of P2X7 signaling, due to high glucose levels, leads to blood retinal barrier (BRB) breakdown, which is a hallmark of diabetic retinopathy (DR). Furthermore, several studies report that high glucose (HG) conditions and the related activation of the P2X7 receptor (P2X7R) lead to the over-expression of pro-inflammatory markers. In order to identify novel P2X7R antagonists, we carried out virtual screening on a focused compound dataset, including indole derivatives and natural compounds such as caffeic acid phenethyl ester derivatives, flavonoids, and diterpenoids. Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) rescoring and structural fingerprint clustering of docking poses from virtual screening highlighted that the diterpenoid dihydrotanshinone (DHTS) clustered with the well-known P2X7R antagonist JNJ47965567. A human-based in vitro BRB model made of retinal pericytes, astrocytes, and endothelial cells was used to assess the potential protective effect of DHTS against HG and 2′(3′)-O-(4-Benzoylbenzoyl)adenosine-5′-triphosphate (BzATP), a P2X7R agonist, insult. We found that HG/BzATP exposure generated BRB breakdown by enhancing barrier permeability (trans-endothelial electrical resistance (TEER)) and reducing the levels of ZO-1 and VE-cadherin junction proteins as well as of the Cx-43 mRNA expression levels. Furthermore, HG levels and P2X7R agonist treatment led to increased expression of pro-inflammatory mediators (TLR-4, IL-1β, IL-6, TNF-α, and IL-8) and other molecular markers (P2X7R, VEGF-A, and ICAM-1), along with enhanced production of reactive oxygen species. Treatment with DHTS preserved the BRB integrity from HG/BzATP damage. The protective effects of DHTS were also compared to the validated P2X7R antagonist, JNJ47965567. In conclusion, we provided new findings pointing out the therapeutic potential of DHTS, which is an inhibitor of P2X7R, in terms of preventing and/or counteracting the BRB dysfunctions elicited by HG conditions. View Full-Text
Keywords: diabetic retinopathy; blood-retinal barrier; purinergic P2X7 receptor; endothelial cells; oxidative stress; inflammation diabetic retinopathy; blood-retinal barrier; purinergic P2X7 receptor; endothelial cells; oxidative stress; inflammation
Show Figures

Figure 1

MDPI and ACS Style

Fresta, C.G.; Caruso, G.; Fidilio, A.; Platania, C.B.M.; Musso, N.; Caraci, F.; Drago, F.; Bucolo, C. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor. Int. J. Mol. Sci. 2020, 21, 9305. https://doi.org/10.3390/ijms21239305

AMA Style

Fresta CG, Caruso G, Fidilio A, Platania CBM, Musso N, Caraci F, Drago F, Bucolo C. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor. International Journal of Molecular Sciences. 2020; 21(23):9305. https://doi.org/10.3390/ijms21239305

Chicago/Turabian Style

Fresta, Claudia G., Giuseppe Caruso, Annamaria Fidilio, Chiara B.M. Platania, Nicolò Musso, Filippo Caraci, Filippo Drago, and Claudio Bucolo. 2020. "Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor" International Journal of Molecular Sciences 21, no. 23: 9305. https://doi.org/10.3390/ijms21239305

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop